BCLIBrainstorm Cell Therapeutics Inc.
0.7109USD-10.01%Mkt Cap: 7.84M USDP/E: Last update: 2026-06-01

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn propriet…

Indicators:|

Key Statistics

Company
Market Cap7.84M USD
Enterprise Value9.42M USD
Revenue (TTM)
Gross Profit
Net Income (TTM)-10.31M USD
Revenue/Share
Last Price0.7109 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS10501E2019
Valuation
P/E (Trailing)
P/E (Forward)-0.92
PEG
EV/EBITDA-0.97
EV/Revenue
P/S
P/B-0.87
EPS (TTM)-0.85
EPS (Forward)-0.86
52W Range
0.460029% of range1.330
52W High1.330 USD
52W Low0.4600 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE103.22%
ROA-1008.51%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-6.97M USD
CapEx (TTM)
FCF Margin
FCF Yield-40.94%
Net Debt1.15M USD
Net Debt/EBITDA-0.12
Balance Sheet
Debt/Equity-0.02
Current Ratio0.03
Quick Ratio0.01
Book Value/Sh-0.9050 USD
Cash/Share0.0030 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:15
Split DateOct 1, 2024
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.11.03M
Float9.97M
Insiders9.36%
Institutions0.00%
Short Interest
Short Ratio1.3d
Short % Float6.46%
Short % Out.5.97%
Shares Short604.46K
Short (prev mo.)536.94K
Technical
SMA 500.7854 (-9.5%)
SMA 2000.6822 (+4.2%)
Beta0.21
S&P 52W Chg27.94%
Avg Vol (30d)8.95K
Avg Vol (10d)11.23K
Technical Indicators
RSI (14)60.2
MACD-0.0097
MACD Signal-0.0218
MACD Hist.+0.0121
BB Upper0.7539 USD
BB Middle0.6930 USD
BB Lower0.6321 USD
BB Width17.58%
ATR (14)0.0748 USD
Vol Ratio (20d)0.06x